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Purpose: Cataracts are a clinically and genetically heterogeneous disorder affecting the ocular lens, and the leading cause
of treatable vision loss and blindness worldwide. Here we identify a novel gene linked with a rare autosomal dominant
form of childhood cataracts segregating in a four generation pedigree, and further show that this gene is likely associated
with much more common forms of age-related cataracts in a case-control cohort.
Methods: Genomic DNA was prepared from blood leukocytes, and genotyping was performed by means of single
nucleotide polymorphism (SNP) markers, and short tandem repeat (STR) markers. Linkage analyses were performed with
the GeneHunter and MLINK programs, and association analyses were performed with the Haploview and Exemplar
programs. Mutation detection was achieved by PCR amplification of exons and di-deoxy cycle-sequencing.
Results: Genome-wide linkage analysis with SNP markers, identified a likely disease-haplotype interval on chromosome
1p (rs707455-[~10 Mb]-rs477558). Linkage to chromosome 1p was confirmed using STR markers D1S2672 (LOD score
[Z]=3.56, recombination distance [θ]=0), and D1S2697 (Z=2.92, θ=0). Mutation profiling of positional-candidate genes
detected a heterozygous transversion (c.2842G>T) in exon 17 of the gene coding for Eph-receptor type-A2 (EPHA2) that
cosegregated with the disease. This missense change was predicted to result in the non-conservative substitution of a
tryptophan residue for a phylogenetically conserved glycine residue at codon 948 (p.G948W), within a conserved
cytoplasmic domain of the receptor. Candidate gene association analysis further identified SNPs in the EPHA2 region of
chromosome 1p that were suggestively associated with age-related cataracts (p=0.007 for cortical cataracts, and p=0.01
for cortical and/or nuclear cataracts).
Conclusions: These data provide the first evidence that EPHA2, which functions in the Eph-ephrin bidirectional signaling
pathway of mammalian cells, plays a vital role in maintaining lens transparency.
Light  scattering  opacities  of  the  crystalline  lens,  or
cataracts, are a common ocular symptom of aging (>50 years),
and despite advances in their surgical treatment age-related
cataracts  remain  a  leading  cause  of  visual  impairment,
accounting for ~40% of world blindness [1]. Rarely, cataracts
may present at birth (congenital), during infancy or during
childhood with an estimated prevalence of 1–13 cases/10,000
live births [2], and are clinically important as a cause of
impaired form vision development accounting for 5%–20%
of childhood blindness [3]. As much as 40% of early-onset
cataracts may have a genetic basis [2], either as a recognized
feature of over 50 genetic syndromes, involving other ocular
defects  (e.g.,  microphthalmia)  and  systemic  abnormalities
(e.g., galactokinase deficiency), or more often as an isolated
lens phenotype with autosomal dominant inheritance (Online
Mendelian  Inheritance  in  Man;  OMIM).  To  date,  genetic
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linkage studies of over 70 extended families worldwide have
mapped at least 25 independent loci for clinically diverse
forms of nonsyndromic cataracts on 18 human chromosomes
[4]. The majority of underlying mutations have been identified
in  10  crystallin  genes
(CRYAA,CRYAB,CRYBB1,CRYBB2,CRYBB3,CRYBA3/
A1,CRYBA4,CRYGC,GRYGD,  and  CRYGS)  [5-13]  and  2
connexin  genes  (GJA3,GJA8)  [14,15],  which  encode  the
major “refractive” proteins and gap-junction-channel proteins
of the lens, respectively. The remaining mutations have been
identified  in  at  least  10  other  functionally  diverse  genes
including  those  coding  for  transcription  factors
(HSF4,MAF,PITX3)  [16-18],  an  aquaporin  water  channel
(MIP)  [19],  cell-junction-like  proteins  (LIM2,TMEM114)
[20,21], intermediate-filament-like proteins (BFSP2,BFSP1)
[22,23], a chromatin modifying protein (CHMP4B) [24], and
a solute carrier protein (SLC16A12) [25].
In addition to conventional linkage studies of inherited
cataracts  in  extended  families,  sibling  and  twin  studies
indicate that genetic risk factors may account for 14%–48%
of the heritability for age-related “nuclear” cataracts [26-28],
and 24%–75% of the heritability for age-related “cortical”
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chromosomecataracts [29-31]. In contrast to inherited cataracts; however,
comparatively little is known about the underlying genetic
determinants  predisposing  to  age-related  cataracts  [32].
Genes linked with inherited forms of cataracts represent likely
candidate genes for age-related cataracts; however, only the
“Osaka”  variation  (p.A198V)  in  the  gene  for  autosomal
recessive galactokinase-deficiency and congenital cataracts
(GALK1) has so far been associated unambiguously with age-
related cataracts, and this association appears to be limited to
East Asian populations [33,34]. Here we report for the first
time that variations in the gene for Eph-receptor tyrosine
kinase-type  A2  (EPHA2)  on  1p36  are  associated  with
inherited and age-related forms of cataracts in Caucasians.
METHODS
Family participants: A white American family of Western
European  origin  (family  Mu)  was  ascertained  through
ophthalmic records in the Department of Ophthalmology and
Visual  Sciences  at  Washington  University  School  of
Medicine, St. Louis, MO. Blood samples were obtained from
18 family members including 12 affected individuals, one
unaffected individual, and five spouses. Leukocyte genomic
DNA  was  purified  using  the  Gentra  Puregene  Blood  kit
(Qiagen,  Valencia,  CA),  and  quantified  by  absorbance  at
260nm  (GeneQuant  pro;  GE  Healthcare,  Waukesha,  WI).
Ethical  approval  for  this  study  was  obtained  from  the
Washington University Human Research Protection Office,
and written informed consent was provided by all participants
before  enrollment  in  accordance  with  the  tenets  of  the
Declaration of Helsinki, and Health Insurance Portability and
Accountability Act (HIPAA) regulations.
Case-control participants: A case-control cohort of unrelated
individuals  aged  >50  years  form  Northern  Italy  was
ascertained from the Clinical Trial of Nutritional Supplements
and Age-Related Cataract Study [35]. Genomic DNA was
purified from blood samples as described previously [34], and
lens  status  was  evaluated  by  grading  slit-lamp  and  retro-
illumination lens photographs according to a modification of
the  Age-Related  Eye  Disease  Study  (AREDS)  cataract
grading system [36]. Briefly, a clear lens was defined by the
following  grades  at  the  last  available  grading:  nuclear
opalescence <3.0; cortical opacity <5% within the five mm
diameter (dia) circle at the center of the pupil, and <15%
outside this central five mm dia circle; posterior sub-capsular
opacity <1.0 % within the five mm dia central circle. A lens
was defined as cataractous when at least one type of opacity
was present with one or more of the following grades: nuclear
opalescence ≥4.5; cortical opacity >25% inside five mm dia
central  circle  and/or  >25%  outside  five  mm  dia  circle;
posterior sub-capsular opacity >12.5% inside five mm dia
circle. Ethical approval for this study was obtained from the
University  of  Parma  and  the  National  Eye  Institute,  and
written informed consent was provided in accordance with the
tenets of the Declaration of Helsinki.
SNP  genotyping  and  linkage  analysis:  For  genome-wide
linkage analysis, genotyping was performed by means of the
HumanLinkage-12 Genotyping Beadchip and the Infinium-II
whole-genome amplification and single-base extension assay
(Illumina, San Diego CA) in the Microarray Core Facility at
Washington  University  Genome  Center.  Parametric
multipoint  linkage  analysis  performed  with  GeneHunter
version  2.1r5  from  the  easyLINKAGE  Plus  version  5.08
package [37]. SNP marker allele frequencies used for linkage
analysis were those calculated for Caucasians by the HapMap
project. A gene frequency of 0.001 and a penetrance of 100%
were  assumed  for  the  disease  locus.  Computation  was
performed with GeneHunter in sets of 100 markers.
STR genotyping and linkage analysis: STR markers from the
National  Center  for  Biotechnology  Information  (NCBI)
combined  Généthon,  Marshfield,  and  deCODE  genetic
linkage  maps  were  genotyped  by  means  of  a  4200  DNA
analyzer running Gene ImagIR software (Li-Cor, Lincoln,
NE) as described previously [38]. Pedigree and haplotype data
were managed using Cyrillic (v.2.1) software (FamilyGenetix
Ltd., Reading, UK), and two-point LOD scores (Z) calculated
using the MLINK sub-program from the LINKAGE (5.1)
package of programs [39]. Marker allele frequencies were
assumed to be equal, and a gene frequency of 0.0001 with a
penetrance of 100% were assumed for the disease locus.
Mutation analysis: The genomic sequence for EPHA2 was
obtained  from  the  Ensembl  human  genome  browser,  and
gene-specific  M13-tailed  PCR  primers  (Table  1)  were
selected from the NCBI re-sequencing amplicon (RSA) probe
database. Genomic DNA (2.5 ng/ul, 20 ul reactions), was
amplified (35–40 cycles) in a GeneAmp 9700 thermal cycler
using  AmpliTaq  polymerase  (Applied  Biosystems,  Foster
City, CA) and gene-specific primers (10 pmol). Resulting
PCR amplicons (~250–650 bp) were either enzyme-purified
with ExoSAP-IT (USB Corporation, Cleveland, OH) or gel-
purified  with  the  QIAquick  gel-extraction  kit  (Qiagen).
Purified  amplicons  were  direct  cycle-sequenced  in  both
directions  with  BigDye  Terminator  Ready  Reaction  Mix
(version 3.1) containing M13 forward or reverse sequencing
primers then ethanol precipitated and detected by capillary
electrophoresis  on  a  3130xl  Genetic  Analyzer  running
Sequence  Analysis  (version  5.2)  software  (Applied
Biosystems),  and  Chromas  (version  2.23)  software
(Technelysium, Tewantin, Queensland, Australia). For allele-
specific  PCR  analysis,  exon-17  was  amplified  with  three
primers  (Ex17R1,  Ex17SF,  and  T-alleleF;  Table  1),  and
resulting  amplicons  were  visualized  at  302  nm  following
electrophoresis  in  3%  agarose-gels  stained  with  GelRed
(Biotium, Hayward, CA).
SNP association analysis: For association studies, tagging
SNPs covering the EPHA2 region were selected from the
HapMap database using the Haploview program [40]. SNPs
were  genotyped  by  a  combination  of  TaqMan  melt-curve
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base  extension  assays  (Applied  Biosystems),  and  direct
BigDye Terminator cycle-sequencing (Applied Biosystems).
TaqMan assays were run on a 7900 HT real-time PCR system
(Applied Biosystems). SNaPshot assays and di-deoxy cycle-
sequencing  were  performed  on  a  3130  DNA  analyzer
(Applied Biosystems), and sequence analysis was performed
with the Mutation Surveyor program (Soft Genetics, State
College, PA).
Statistical  analyses:  Tagging  SNPs  and  haplotype  blocks
were  identified  using  the  Haploview  program  [40],  and
association statistics including χ2, trend p values, and odds
TABLE 1. PCR PRIMERS FOR MUTATION-PROFILING OF EPHA2.
Primer Location Strand Sequence (5′-3′)
Ex1F Intron-1 Antisense gcgaccaagctgaaaccgcttatt
Ex1R 5′-upstream Sense ggcatgaatgaacaggagtcggtt
Ex2F Intron-2 Antisense cgtaccttcccacgcccatc
Ex2R Intron-1 Sense ccagcctgctgtgtgccttc
Ex3F1 Exon-3 Antisense ACGGCATGGTCCACACAGGT
Ex3R1 Intron-2 Sense ccaggcacctgcccacacta
Ex3F2 Intron-3 Antisense aaggaaactgatgtctgggaagga
Ex3R2 Exon-3 Sense CCAGAAGCGCCTGTTCACCA
Ex4F Exon-5 Antisense CAGACTCGGGCCAGCACTGT
Ex4R Intron-3 Sense ttcctgggtgcccggtacat
Ex5F Intron-5 Antisense gacactgtgcctttaaccacttgctc
Ex5R Exon-4 Sense GCTTCTTCCGGGCACCTCAG
Ex6F Intron-6 Antisense ctctgctgtgctgccttggg
Ex6R Intron-5 Sense tgcctgctcgtaggcagctt
Ex7F Intron-7 Antisense ccgccggtgaccgagaaag
Ex7R Intron-6 Sense ggcgtccttggaagaggcag
Ex8F Intron-8 Antisense gattcctgcctgcgtgtcca
Ex8R Intron-7 Sense tggagccttcccaagtgcaa
Ex9/10F Intron-10 Antisense accaccgctgcctcctca
Ex9/10R Intron-8 Sense tgggccgcattctgagcac
Ex10/11F Intron-11 Antisense cctctccacccagtgtgggc
Ex10/11R Intron-9 Sense cccacagcctggtccaagtc
Ex12F Exon-13 Antisense TGGTGGTGTAGGTGGCCTCG
Ex12R Intron-11 Sense tacctctgcccactcctccg
Ex13F Exon-14 Antisense CGTCGCTGGCAGAGGTGAAC
Ex13R Exon-12 Sense CCCTGGACAAGTTCCTTCGGg
Ex14F Intron-14 Antisense aactgtcctctgcccagccc
Ex14R Exon-13 Sense CGAGGCCACCTACACCACCA
Ex15F Intron-15 Antisense ctgggccatcgtgtccagtc
Ex15R Intron-14 Sense gggcagctctgaaggttggg
Ex16F Intron-16 Antisense tggcggagttctgcccttct
Ex16R Intron-15 Sense gactgggcttccctgttgcc
Ex17F1 Exon-17 Antisense agggaccgctttgggtctca
Ex17R1 Intron-16 Sense ctctccctctctccctcccg
Ex17F2 Exon-17 Antisense ccctgccacacacacacattc
Ex17R2 Exon-17 Sense agtggcctccctgctgtgc
Ex17F3 3′-downstream Antisense gctcccagggttaagtgacgtg
Ex17R3 Exon-17 Sense gcagactgtgaacttgactgggtga
T-alleleF Exon-17 Antisense GCCGGGCAGCCGCACCCA
Ex17SF Exon-17 Antisense ggaggccactctgtttcttcaagt
Gene  specific  primers  used  for  amplification  and  sequencing  of  exons  1–17  and  flanking intron  regions  of  EPHA2 on
chromosome 1p. Coding and noncoding sequence are shown in uppercase and lowercase, respectively. Antisense primers were
5′-tailed with the M13-forward universal sequence (5′-tgtaaaacgacggccagt), and sense primers were 5′-tailed with the M13-
reverse universal sequence (5′-caggaaacagctatgacc). The allele-specific primer (T-alleleF) was used to detect the heterozygous
c.2842G>T transversion in exon-17 as shown in Figure 3.
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4.04  (Sapio  Sciences,  York,  PA).  Hardy–Weinberg
equilibrium was assessed using a χ2 test implemented in the
Exemplar program.
RESULTS
Linkage  studies:  We  investigated  a  four  generation  white
family  from  the  United  States  (family  Mu)  segregating
“posterior  polar”  cataracts  in  the  absence  of  systemic
abnormalities (Figure 1A). Autosomal dominant inheritance
was supported by father-to-son transmission in the absence of
gender bias or skipping of generations. Ophthalmic records
indicated that the cataracts usually presented in both eyes as
disc-shaped posterior sub-capsular opacities with evidence of
posterior lenticonus (Figure 1B). In three affected individuals,
opacification progressed to affect the central (nucleus) and
anterior polar regions of the lens (IV:5, IV:6, IV:7; Figure 1A).
In addition to cataracts, one affected individual had monocular
amblyopia  (III:8),  and  two  others  developed  strabismus
requiring  corrective  surgery  (IV:1,  IV:5).  The  age-at-
diagnosis varied from birth to15 years, and the age-at-surgery
ranged  from  0  to  44  years.  Post-surgical  corrected  visual
acuity varied from 20/20 to 20/70 in the better eye.
For  genome-wide  linkage  analysis,  the  12  affected
individuals in family Mu were genotyped by means of the
HumanLinkage-12 Panel (Illumina), which comprises 6090
SNP markers uniformly spaced at an average genetic distance
of 0.58 cM. Parametric multipoint analysis performed with
GeneHunter (v2.1r5) detected significant evidence of linkage
(Figure 2) on chromosome 1p (pLOD 3.3), and weak evidence
of  linkage  on  chromosome  17p  (pLOD  1.8).  Haplotype
reconstruction further identified a common disease interval on
1p36 (rs707455-[~10Mb]-rs477558) that cosegregated with
the disease in all 12 affected individuals (Table 2).
To validate the authentic SNP interval from the genome-
wide linkage scan, all 18 family members were genotyped
with STR markers. We first excluded false-positive linkage to
the SNP interval on 17p using markers D17S1852 (Z=-3.75,
θ=0)  and  D17S921  (Z=-∞,  θ=0,  data  not  shown).
Subsequently, we obtained confirmatory evidence of linkage
on  1p  (Table  3)  for  markers  D1S2672  (Z=3.56,  θ=0),
D1S2697  (Z=2.92,  θ=0),  and  D1S436  (Z=2.84,  θ=0).
Haplotype  analysis  detected  four  recombinant  individuals
within the Mu pedigree (Figure 1A). An affected female (III:
8), her affected son (IV:5), and two affected daughters (IV:6,
IV:7) were obligate recombinants distal to the centromere at
D1S214. In addition, one of the affected daughters (IV:6) was
recombinant  proximal  to  the  centromere  at  D1S2644.
However, no further recombinant individuals were detected
at five other intervening STR markers, consistent with the
cataract locus residing in the physical interval, D1S214-(~12
Mb)-D1S2644 (Figure 1C), which was coincident with the
SNP interval on 1p.
Mutation analysis: The SNP and STR intervals contained 211
and  219  positional-candidate  genes,  respectively,  none  of
which were obvious functional candidates for cataracts in
family Mu (NCBI Map Viewer). We prioritized genes for
mutation analysis of exons and intron boundaries (splice-
sites) primarily based on evidence of expression or function
in the eye, from the NCBI UniGene expressed sequence tag
(EST) database, and the NEIBank bioinformatics resource for
vision research [41]. Re-sequencing analysis of individuals II:
1, III:8, and III:9 from the Mu pedigree (Figure 1A) excluded
the presence of coding or splice-site mutations in several
genes including ENO1 (GeneID: 2023), which according to
NEIBank  is  abundantly  expressed  in  the  human  lens.
However,  re-sequencing  of  a  17-exon  gene  symbolized
EPHA2 (GeneID: 1969), which is also expressed in human
lens  (NEIBank),  identified  a  heterozygous  c.2842G>T
TABLE 2. SNP DISEASE HAPLOTYPE FOR THE CATARACT-LINKED INTERVAL ON CHROMOSOME 1P.
  SNP   Disease allele                Distance from 1-ptel
  Mb   cM
rs707455   *   C   7.75   13.68
rs8627   A   8.34   14.21
rs1473420   A   8.54   14.48
rs916380   A   9.26   15.43
rs630075   T   9.29   15.47
rs6677649   A   9.67   16.64
rs2119508   G   9.78   16.66
rs2379107   A   9.83   16.67
rs7528979   C   10.02   16.70
rs6541085   A   10.21   16.73
rs912962   T   10.27   16.74
rs649101   T   10.41   16.77
rs2506887   A   10.51   16.78
rs481453   T   10.60   16.99
rs488834   T   10.69   17.33
rs7555879   G   10.81   17.76
rs2273348   C   11.00   18.43
rs4846012   G   11.48   20.07
rs2817594   A   11.54   20.24
rs3818157   G   11.95   21.26
rs235256   C   12.22   21.31
rs761162   A   14.24   24.73
rs1416633   C   14.36   24.96
rs7531416   A   14.62   25.58
rs3927648   A   14.74   25.86
rs1883661   A   14.88   26.20
rs4357518   A   14.95   26.46
rs3845596   T   15.06   26.91
rs7515649   C   15.31   27.49
rs488595   G   15.56   27.95
rs1007150   T   16.49   29.61
rs761423   G   17.17   30.83
rs1005753   A   17.32   31.08
rs3766306   T   17.84   32.02
rs1578215   G   17.99   32.31
rs477558   **   G   18.09   32.53
The disease associated allele is shown for each SNP in the
cataract interval, which spans ~10 megabases (Mb) or ~19
centi-Morgans  (cM).  The  asterisk  denotes  critical
recombinant individual III:8 in family Mu (Figure 1A) with
genotype T/T at rs707455. The double asterisk denotes critical
recombinant individual IV:6 (Figure 1A) with genotype A/A
at rs477558.
Molecular Vision 2008; 14:2042-2055 <http://www.molvis.org/molvis/v14/a241> © 2008 Molecular Vision
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(Figure 3B). This single nucleotide change did not result in
the gain or loss of a convenient restriction site, therefore we
designed allele-specific (G/T) PCR analysis to confirm that
the  mutant  “T”  allele  cosegregated  with  affected  but  not
unaffected members of family Mu (Figure 3C). Furthermore,
when we tested the c.2842G>T transversion as a bi-allelic
marker, with a notional allelic frequency of 1%, in a two-point
LOD score analysis of the cataract locus (Table 3) we obtained
further  compelling  evidence  of  linkage  (Z=3.61,  θ=0).  In
addition, we confirmed that the c.2842G>T transversion was
not listed in the NCBI SNP database (dbSNP), and excluded
it as a SNP in a panel of 192 normal unrelated individuals (i.e.,
384  chromosomes)  using  the  allele-specific  PCR  analysis
described in Figure 3C (data not shown). While it is possible
that an undetected mutation lay elsewhere within the disease-
haplotype interval, our genotype data strongly suggested that
the c.2842G>T transversion in exon 17 of EPHA2 represented
a causative mutation rather than a benign SNP in linkage
disequilibrium with the cataract phenotype.
The c.2842G>T transversion identified above occurred at
the first base of codon 948 (GGG >TGG), and was predicted
to result in the missense substitution of glycine to tryptophan
(p.G948W) at the level of translation (Figure 4), placing it in
the cytoplasmic sterile-α-motif (SAM) domain of EPHA2
[42,43]. Cross-species alignment of the amino acid sequences
for EPHA2 present in the Entrez protein database, performed
by means of ClustalW multiple sequence alignment, revealed
that  p.G948  is  evolutionarily  conserved  within  the  bony
vertebrates (Figure 4B). Moreover, the predicted p.G948W
substitution  represented  a  nonconservative  amino  acid
change,  with  the  small  neutral,  polar  side-group  (-H)  of
Figure 1. Autosomal dominant posterior polar cataracts in a four generation white American pedigree (family Mu). A: Pedigree and haplotype
analysis showing segregation of seven STR markers on chromosome 1p listed in descending order from the telomere. Squares and circles
denote males and females, respectively. Filled symbols and bars denote affected status and haplotypes, respectively. B: Slit-lamp image of
left lens from affected female IV:6 (age 12 years) showing posterior sub-capsular opacity. C: Ideogram of chromosome 1p36, comparing the
cytogenetic and physical locations of STR markers defining the posterior polar cataract locus in this study (red) with those defining 3 other
loci (black) for autosomal dominant cataracts (CCV, CTPP1 and Total) [45-47], and a locus (blue) for age-related cortical cataracts [44]. M,
mega-base pairs.
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side-group (-CH2-C8 H4NH) of tryptophan. Position specific
score  matrix  analysis  (PSSM  Viewer)  revealed  a  marked
decline in value from +6 to −6 (Table 4) confirming that the
predicted p.G948W substitution occurred less frequently than
expected  in  proteins  with  the  conserved  SAM  domain
(Conserved  Domain  Database  [CDD]  pfam00536)  further
raising the likelihood of functional consequences.
Association studies: EPHA2 resides within a large interval
(D1S468-[~25.5 Mb]-D1S1622) on chromosome 1p (Figure
1C)  that  was  previously  linked  with  age-related  cortical
cataracts in families and sib-pairs from the Beaver Dam Eye
Study [44]. To investigate the possibility that EPHA2 was
associated  with  age-related  cataracts,  we  performed
candidate-gene  SNP  allele  association  studies  in  a  case-
control cohort from Northern Italy [34,35]. This clinically
well defined cohort was of similar European ancestry to that
Figure 2. Parametric multipoint LOD scores (pLOD) for linkage between the posterior polar cataract phenotype in family Mu and SNP markers
across the 22 autosomes.
TABLE 3. TWO-POINT LOD SCORES (Z) FOR LINKAGE BETWEEN THE CATARACT LOCUS IN FAMILY MU AND MARKERS ON CHROMOSOME 1P.
Marker
Distance from 1p-tel Z at θ=
Max θMax cM Mb        0.00            0.05 0.10 0.20 0.30 0.40
D1S2795 14.20 5.50 -0.47 2.24 2.24 1.88 1.33 0.66 2.27 0.07
D1S214 16.40 6.88 -0.44 2.27 2.27 1.91 1.35 0.67 2.30 0.08
rs707455   7.75 -3.70 -0.64 -0.37 -0.15 -0.05 -0.01 0.00 0.05
D1S2736 22.90 10.54 2.62 2.38 2.14 1.62 1.05 0.47 2.62 0.00
D1S489 32.30 11.97 1.54 1.41 1.28 1.01 0.71 0.38 1.54 0.00
D1S507 36.20 14.90 2.61 2.38 2.13 1.60 1.03 0.45 2.61 0.00
D1S2672 36.20 15.15 3.56 3.25 2.93 2.25 1.51 0.71 3.56 0.00
D1S436 39.90 15.74 2.84 2.59 2.32 1.76 1.15 0.52 2.84 0.00
D1S2697 39.90 16.29 2.92 2.66 2.39 1.82 1.20 0.55 2.92 0.00
EPHA2 c.
2842G>T
  16.32–16.36 3.61 3.30 2.98 2.28 1.52 0.72 3.61 0.00
D1S1592   17.94 1.26 1.16 1.05 0.83 0.59 0.32 1.26 0.00
rs477558   18.09 -4.43 -0.57 -0.33 -0.14 -0.06 -0.02 0.00 0.50
D1S2644 46.20 18.90 -∞ -0.38 -0.15 0.03 0.07 0.06 0.07 0.32
Z values for markers on 1p listed in genetic and physical distances measured in cM and Mb, respectively, from the telomere
(1p-tel).  The  maximum Z values (Zmax) occurred at marker D1S2672, and at the c.2842G>T transversion in exon-17 of
EPHA2 . θ=recombination fraction.
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Zof family Mu, and comprised 126 unrelated individuals with
nuclear  cataracts,  119  with  cortical  cataracts,  and  104
unrelated controls with clear lenses (Table 5). Of the cases,
28 had both nuclear and cortical cataracts, three had nuclear
and  posterior  sub-capsular  cataracts,  10  had  cortical  and
posterior  sub-capsular  cataracts,  and  four  had  nuclear,
cortical, and posterior sub-capsular cataracts.
In an initial screen, tagging SNPs covering the EPHA2
region  were  genotyped  using  100  samples  each  from
individuals with any nuclear, any cortical and no age-related
cataracts.  Markers  yielding  p  values  <0.05  were  further
analyzed using the entire complement of samples (Appendix
1,  Figure  5).  All  markers  were  in  Hardy–Weinberg
equilibrium (HWE, p>0.05) for all sample groups tested. The
highest levels of association occurred with rs7543472 (allelic
p<0.038 for cortical cataracts, and allelic p<0.021 for any age
related cataracts) and rs11260867 (allelic p<0.020 for cortical
cataracts), which lie just distal (3′) to EPHA2 (Figure 5).
However, there was no significant association with nuclear
cataracts, although results with rs7543472 were suggestive
(allelic  p<0.071,  Appendix  1).  These  findings  were  true
whether  the  analysis  was  for  pure  cortical  cataracts,  any
Figure 3. Mutation analysis of EPHA2
in family Mu. A: Sequence trace of the
wild type allele showing translation of
glycine  (G)  at  codon  948  (GGG).  B:
Sequence  trace  of  the  mutant  allele
showing the heterozygous c.2842G>T
transversion  (denoted  K  by  the
International Union of Pure and Applied
Chemistry  [IUPAC]  code)  that  is
predicted  to  result  in  the  missense
substitution  of  tryptophan  (TGG)  for
glycine  at  codon  948  (p.G948W).  C:
Allele-specific PCR analysis using the 3
primers (Table 1) indicated by arrows in
the  schematic  diagram;  exon-17  was
amplified  as  above  with  the  sense
(anchor)  primer  located  in  intron  16
(Ex17R1), the anti-sense primer located
in the 3′-untranslated region (Ex17SF),
and the nested mutant primer specific
for the T-allele in codon 948 (T-alleleF).
Note  that  only  affected  members  of
family  Mu  are  heterozygous  for  the
mutant T-allele (80 bp).
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2048cortical  cataracts,  pure  nuclear  cataracts,  or  any  nuclear
cataracts. Since association was seen between SNPs in the
EPHA2 region and cortical cataracts and suggestive results
were  obtained  with  nuclear  cataracts,  the  analysis  was
extended to include any age-related cataracts with subsequent
increased association in SNPs from the peak region to p<0.021
with  the  T-allele  of  rs7543472,  although  the  G-allele  of
rs11260867  actually  lost  significance  slightly  (p=0.076).
Results for SNPs outside this region changed only minimally.
Because the SNPs showing the greatest association lay over
or just beyond exon 17, this region was sequenced in all
samples.  The  only  variation  occurring  with  a  frequency
greater  than  0.05  was  rs3754334,  a  synonymous  p.I958I
(C3011T) variant. This variant had minor allele frequencies
of ~34% in cataract cases and 28% in controls, and was thus
analyzed further, although the association was not as strong
as with the two distal (3′) SNPs (rs7543472 or rs11260867)
and no significant allelic p values were obtained. Allelic odds
ratios ranged from 1.5 to 1.7, for rs7543472, and 1.2–1.9 for
rs11260867, but were not significant for rs3754334. The p
values obtained were not corrected for multiple testing as
these SNPs were tested, a priori, for association with age-
related cataracts on the basis of their close proximity to a gene
linked with inherited cataracts that also maps within a known
linkage region for age-related cataracts, rather than as part of
a genome-wide scan.
Trend p values were very similar to allelic p values for
all SNPs, but the specific genotypes show greater levels of
association  for  all  SNPs  showing  significant  association
(Appendix 1). The most significant was p<0.007 for cortical
cataracts  with  rs11260867  (GG  genotype),  p<0.012  for
cortical cataracts and p<0.01 for any cataracts with rs7543472
(TT genotype), and p<0.019 for cortical cataracts and p<0.028
for any cataracts with rs3754334 (TT genotype). In addition,
association  of  nuclear  cataracts  with  the  TT  genotype  of
rs7543472 is marginally significant at p<0.042 and suggestive
with the TT genotype of rs3754334 at p<0.06. Genotypic odds
ratios  show  the  greatest  risk  increase  in  individuals
Figure 4. Schematic diagram showing gene structure and protein domains of EPHA2. A: Exon-intron organization, mutation profile and protein
domains. Intron sizes are shown in base-pairs (bp), and codons are numbered below each exon (boxes). The approximate locations of protein
domains are indicated. SP, signal-peptide; Eph-lbd, Eph-receptor ligand binding domain; EGF-like, epithelial growth factor-like region; Fn-3,
fibronectin type-III domain; Tm-1, transmembrane domain type-1; Pkinase-Tyr, protein tyrosine kinase domain; SAM, sterile-α-motif. The
predicted p.G948W missense mutation identified in family Mu is proposed to reside in the cytoplasmic SAM domain. B: Amino acid sequence
alignment of the SAM domain from human EPHA2 and orthologs from other species, showing conservation of p.G948. Divergent amino-
acids residues are shaded. The SAM domain comprises an NH2-terminal extended strand (dots), 5 α-helices (H1–5, over-lined), and a core
sub-unit (bolded). The proposed p.G948W substitution likely resides between H-4 and H-5.
TABLE 4. POSITION SPECIFIC SCORE MATRIX (PSSM) ANALYSIS OF THE PREDICTED P.G948W SUBSTITUTION IN EPHA2.
Codon Amino
acid
Side-
chain
Charge Potential H-
bonds
Residue
weight
Isoelectric point Hydro-
phobicity
PSSM
value
GGG G (Gly) -H 0 0 57 6.0 0.770 6
TGG W (Trp) -CH2-C8
H4NH
0 1 186 5.9 0.854 −6
Differences in the physico-chemical properties of glycine and tryptophan are consistent with a non-conservative substitution.
The negative PSSM value indicates that tryptophan substitutes for glycine at position 948 less frequently than expected among
proteins containing the conserved SAM domain.
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2049homozygous for the risk alleles, ranging from 1.9 to 2.1 for
rs7543472,  1.5–2.3  for  rs11260867,  and  2.7–3.3  for
rs3754334, depending on the type of age-related cataracts
being considered (Appendix 1).
The association of a potential risk haplotype for these
three SNPs was examined; however, the association level was
found to be essentially that of the least associated SNP. This
result  was  consistent  with  the  observation  that  all  but  4
affected individuals with the homozygous TT genotype for
rs3754334  also  had  a  homozygous  TT  genotype  for
rs7543472, and all but one had a homozygous GG genotype
for  rs11260867.  Similarly,  of  affected  individuals  with  a
homozygous  TT  genotype  for  rs7543472  only  a  single
individual  did  not  have  a  homozygous  GG  genotype  for
rs11260867. However, because the genotype frequency of TT
for rs3754334 was only ~15% it did not show strong linkage
disequilibrium with rs11260867 (D´=0.018) or rs7543472 (D
´=0.022). In contrast, rs11260867 and rs7543472, for which
the  risk  genotypes  have  frequencies  of  ~80%  and  ~73%
respectively,  showed  strong  linkage     disequilibrium
(D´=0.896).
DISCUSSION
In  this  study,  we  have  mapped  an  interval  on  human
chromosome 1p36 for autosomal dominant posterior polar
cataracts,  and  identified  an  underlying  missense  mutation
(p.G948W) in the gene coding for EPHA2, which has not
previously  been  associated  with  eye  disease.  Our  disease
interval maps in close proximity to autosomal dominant loci
for the Volkman congenital cataract (CCV) in a Danish family
[45], posterior polar cataract (CCTP1) in a British family
[46],  and  total  congenital  cataract  in  a  Tasmanian  family
[47],  raising  the  possibility  of  allelism  (Figure  1C).  In
addition, EPHA2 resides within a large interval (D1S468-
[~25.5 Mb]-D1S1622) on chromosome 1p (Figure 1C) that
was previously linked with age-related cortical cataracts in
families and sib-pairs from Beaver Dam, Wisconsin [44].
Here, we further demonstrate that variations in the EPHA2
region  are  associated  with  age-related  cortical  cataracts
(p=0.007), and age-related cataracts overall (p=0.01) in an
Italian population.
EPHA2 encodes a 976 amino acid, type-1 transmembrane
protein  (~108  kDa)  with  extracellular  NH2-terminal  and
cytoplasmic COOH-terminal halves (Figure 4B) [42]. The
extracellular  region  comprises  a  conserved  Eph-ligand
binding domain followed by a cysteine-rich EGF-like domain,
and two fibronectin type-III repeats, whereas, the cytoplasmic
region contains a conserved tyrosine kinase domain, and a
sterile-α-motif (SAM) domain [42]. The proposed p.G948W
missense substitution, cosegregating with cataracts in family
Mu, was predicted to reside in the cytoplasmic SAM domain
of  EPHA2.  The  evolutionarily  conserved  ~70  amino  acid
SAM domain has a compact helical structure that is believed
to  facilitate  protein–protein  interactions  [43],  raising  the
possibility  that  the  predicted  p.G948W  substitution  may
interfere with Eph-receptor oligomerization and clustering
into  higher-order  complexes  essential  for  physiologic
signaling [42].
In contrast to the heterozygous genotype and dominant
phenotype linked with the p.G948W mutation in EPHA2, the
SNPs in the EPHA2 region most associated with age-related
cataracts displayed the highest odds ratios when homozygous
for  the  risk  allele,  consistent  with  recessive  effects.
Furthermore,  the  p.G948W  mutation  was  linked  with
posterior polar cataracts, which most resemble age-related
posterior sub-capsular cataracts, whereas, EPHA2 SNPs were
associated with much more prevalent forms of age-related
cataracts,  in  decreasing  order  of  significance;  cortical
opacities  >  any  opacities  >  nuclear  opacities.  While  it  is
problematic to compare inherited and age-related forms of
cataracts, it is noteworthy that some of the affected members
of  family  Mu  also  developed  nuclear  and  anterior  polar
opacities. These observations raise the possibility that EPHA2
variants may contribute to a common pathogenic mechanism
resulting in different cataract phenotypes. The existence of
any such mechanism remains to be determined; however, it is
interesting  that  the  two  SNPs  in  the  EPHA2  region  most
associated  with  age-related  cataracts  (rs7543472  and
TABLE 5. AGE, GENDER AND LENS STATUS OF THE ITALIAN CASE-CONTROL COHORT OF AGE-RELATED CATARACTS.
Lens status Age range Mean age (±2 SD) Males (%) Females (%) Total
Any cortical
cataracts
57–86 75.6 (63.7–87.5) 57 (48) 62 (52) 119
Any nuclear
cataracts
50–86 75.8 (63.0–88.6) 75 (60) 51 (40) 126
Any cataracts 50–86 75.7 (63.2–88.2) 114 (54) 99 (46) 213
Clear lenses 61–86 74.5 (64.6–84.5) 61 (59) 43 (41) 104
The cohort of unrelated individuals comprised a total of 213 age-related cataract cases and 104 clear lens controls, matched for
age and gender. Cases with both nuclear and cortical cataracts (32) were counted in both the any cortical and any nuclear groups.
Cases with any posterior sub-capsular cataracts (17) were not analyzed separately due to statistically insufficient numbers.
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the gene, which has been shown to harbor highly conserved
translational control sequences that are believed to facilitate
an RNA-based post-transcriptional mechanism for localized
regulation of gene expression within cells [48,49].
EPHA2 is a member of the largest sub-family of receptor
tyrosine kinases, which are divided into 2 classes; the A-
subclass comprising 10 receptor genes (EPHA1–10) and the
B-sub-class with 6 receptor genes (EPHB1–6) [50,51]. Eph
receptors  interact  with  their  cognate  membrane-anchored
ligands, referred to as ephrins (EFNA1–6,EFNB1–3), at cell-
cell contact sites to activate bidirectional signaling pathways
effecting  diverse  physiologic  processes  including;  cell
adhesion,  repulsion,  morphology,  and  migration  [50,51].
Intriguingly,  EPHA2  has  been  implicated  in  tumor
angiogenesis and neurite outgrowth; however, little is known
about its role in the development and homeostasis of the
avascular, noninnervated lens. Recently, however, it has been
reported  that  mice  lacking  ephrin-A5,  a  ligand  of  Epha2,
develop  cataracts  as  a  result  of  impaired  lens  fiber  cell
adhesion  [52].  Further  characterization  of  Eph-ephrin
signaling pathways in the lens should provide insight into the
Figure  5.  Graphical  presentation  of
association  between  SNPs  in  the
EPHA2 region of chromosome 1p with
age-related cataracts in the Italian case-
control cohort. The upper panel shows a
plot  of  -log  p-values  (y-axis)  from
association analyses of 21 SNPs across
the  EPHA2  region.  Blue  diamonds
denote -log p values for pure cortical
cataracts;  red  squares,  any  cortical
cataracts; green triangles, pure nuclear
cataracts;  purple  x,  any  nuclear
cataracts; and light blue asterisks, any
cataracts. The x-axis shows the relative
physical location of each SNP measured
in  mega-base-pairs.  The  lower  panel
shows a pairwise linkage disequilibrium
(D´)  Haploview  plot  for  SNPs  in  the
EPHA2 region. The strength of linkage
disequilibrium (LD) is color-coded; red
indicates strong LD with SNPs showing
high correlation, and blue indicates low
LD  and  high  recombination.  The
relative  positions  of  EPHA2  and  the
adjacent FAM131C are indicated with
haplotype  blocks  for  the  European
population  (CEU)  from  the  HapMap
project  (SNPbrowser,  Applied
Biosystems).
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cataractogenesis.
In conclusion, our data have associated EPHA2 with both
inherited  and  age-related  cataracts,  and  suggest  that
dysfunction of a member of the EphA-receptor tyrosine kinase
sub-family triggers loss of lens transparency.
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105:16620-5. [PMID: 18948590]Appendix 1. Association results for SNPs in the EPHA2 region with age-
related cataracts.
Calculated  significance  values  (p=< 0.05)  show  most
association between rs11260867 and any cortical cataracts,
and between rs7543472 and any cataracts. To access the data,
click or select the words “Appendix 1.” This will initiate the
download of a compressed (pdf) archive that contains the file.
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